—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Kiniksa Pharmaceuticals Ltd (KNSA) — Technical state

As of 2026-10-30 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 57 out of 100 (momentum 97 · quality 59 · valuation 19), as of 2026-11-01.
  • Signal: Uptrend stack intact — Trades +16.5% vs the 50-day and +53.2% vs the 200-day average, 6.3% below the 52-week high and +152.3% off the 52-week low. Computed from daily closes. (as of 2026-10-30)
  • Trend: Kiniksa Pharmaceuticals Ltd trades 16.5% above its 50-day and 53.2% above its 200-day moving average. (as of 2026-10-30)

Kiniksa Pharmaceuticals is a biopharmaceutical company that develops and sells therapies for autoinflammatory and cardiovascular conditions. Its approved medicine, Arcalyst, treats recurrent pericarditis, a chronic inflammation of the tissue around the heart, and cardiac sarcoidosis.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the KNSA overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +16.5% vs the 50-day and +53.2% vs the 200-day average, 6.3% below the 52-week high and +152.3% off the 52-week low. Computed from daily closes.

Ranked #19 on today’s Directional Flow — Getting stronger list (scan of 2026-11-02).

The moving-average stack

Continue: the KNSA chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-10-30

Quick answers

What is the current Closelooknet signal on KNSA?

Uptrend stack intact — Trades +16.5% vs the 50-day and +53.2% vs the 200-day average, 6.3% below the 52-week high and +152.3% off the 52-week low. Computed from daily closes. As of 2026-10-30; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is KNSA above its 50-day and 200-day moving averages?

As of 2026-10-30, Kiniksa Pharmaceuticals Ltd trades +16.5% above its 50-day and +53.2% above its 200-day average, with the 20-day +13% away.

How far is KNSA from its 52-week high?

6.3% below the 52-week high and 152.3% above the 52-week low, as of 2026-10-30.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.